ULBI - Ultralife Corporation

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue82,46076,42766,494
Cost of Revenue57,35253,11147,144
Gross Profit25,10823,31619,350
Operating Expenses
Research Development5,9465,6035,333
Selling General and Administrative15,39914,23315,460
Non Recurring-150150
Others---
Total Operating Expenses---
Operating Income or Loss3,7633,330-1,443
Income from Continuing Operations
Total Other Income/Expenses Net8068-141
Earnings Before Interest and Taxes3,8433,398-1,584
Interest Expense263248218
Income Before Tax3,5803,150-1,802
Income Tax Expense98310268
Minority Interest-170-143-114
Net Income From Continuing Ops3,5092,869-2,070
Non-recurring Events
Discontinued Operations---61
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income3,5092,869-2,116
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares3,5092,869-2,116